Daiichi Sankyo selects research partners for TaNeDS Collaborative Drug Discovery project

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has selected research partners for its TaNeDS (Take a New challenge for Drug diScovery) collaborative drug discovery project. The researchers were selected from universities and public research centers in Japan. Daiichi Sankyo will soon begin signing agreements with the selected parties to initiate collaborative research.

1. Total entries: 222
2. Selected parties: 23
3. Selections by entry type

   

4. Selections by research theme

   

* Daiichi Sankyo RD Novare Co., Ltd. (hereafter, RD Novare), Daiichi Sankyo’s wholly owned subsidiary, joined TaNeDS to promote the development of novel technology platforms for drug discovery, in 2013.

Project overview

• How to apply

*Project duration subject to change based on research
Target project numbers: 18 for A, and 2 for B

A. Desired research themes by Daiichi Sankyo: 1) Exploratory research themes and research themes that will lead to initial drug discovery in the idea stage; 2) research themes that will lead to practical application of intellectual properties and proprietary know-how; and 3) technologies being researched academically that are applicable to solving challenges faced in terms of pharmaceutical manufacturing process development and quality assurance will be accepted. Daiichi Sankyo will determine if feasibility studies with Daiichi Sankyo researchers (preliminary collaborative research) or collaborative research should be conducted based on proposed themes. Accepted themes will be selected for continuation based on results after the research period comes to a close.

B. Desired research themes by RD Novare: Research themes that will lead to the development of the novel technology platforms related to drug discovery will be accepted. Scientists at RD Novare work together on technological seeds being researched academically by applicants to establish leading edge technology platforms and biological evaluation methods.

• Desired research themes

– Desired research themes by Daiichi Sankyo
i. Oncology
ii Cardiovascular metabolics (metabolic disease, heart disease and vascular disease)
iii Leading edge pharmaceuticals
iv Enhancement of current research projects
v Antibodies
vi Nucleic acid therapeutics, peptide pharmaceuticals, DDS
vii Biomarkers
viii Drug Safety, ADME (Drug Absorption, Distribution, Metabolism, Excretion)
ix Pharmaceutical technology platforms

– Desired research themes by RD Novare
i. Drug discovery and development technology platform research

* For more information about the TaNeDS program visit the Daiichi Sankyo corporate website: http://www.daiichisankyo.co.jp/corporate/rd/taneds/

•  Who is eligible

Researchers from universities and public research centers who can conduct research in Japan

• Schedule

Application period: May 20 to June 14, 2013
First selection period: June 17 to July 31, 2013
Second selection period: August 1 to September 30, 2013
Contract negotiation: From October 1, 2013
Start of research: Upon completion of contract